OPG has been demonstrated to be the independent predictor of MS even after adjusting for age, gender, ethnicity, glucose and microvascular complications [9] and consequently, OPG has been suggested as a target of therapy in T2DM [38]. Here, TNFRSF11B is linked to type 2 diabetes mellitus.